TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
ACHIM Biotherapeutics AB
Closing information (x1000 NOK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
2
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-216
|
-193
|
-327 |
| EBITDA |
-216
|
-193
|
-327 |
| Total assets |
205
|
151
|
251 |
| Current assets |
205
|
151
|
251 |
| Current liabilities |
41
|
69
|
78 |
| Equity capital |
162
|
80
|
170 |
| - share capital |
119
|
150
|
149 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
79.0%
|
53.0%
|
67.7% |
| Turnover per employee |
2
|
0
|
0 |
| Profit as a percentage of turnover | -10800% | ||
| Return on assets (ROA) |
-105.4%
|
-127.8%
|
-130.3% |
| Current ratio |
500%
|
218.8%
|
321.8% |
| Return on equity (ROE) |
-133.3%
|
-241.2%
|
-192.4% |
| Change turnover |
2
|
0
|
-837 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.